Takahiro Miyazaki

VP, Head of Research

Moderna Therapeutics (United States)

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takahiro Miyazaki serves as the VP and Head of Research at Nektar Therapeutics in the United States. His research focuses on immunotherapy, specifically enhancing the efficacy of CD19-targeted CAR T-cell treatments and improving natural killer cell function in multiple myeloma. Recent publications highlight the development of innovative polymer-conjugated human IL-15 products and their unique mechanisms of action.

Articles (4)

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Collaborators (1)

Jordan Gauthier

Assistant Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takahiro Miyazaki

Research Interests

Explore related searches

Contact this professor

About

Articles (4)

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15

NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells

Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.

Collaborators (1)

Jordan Gauthier

Make your next move.